Akebia Therapeutics Inc. buy HC Wainwright
Start price
28.08.23
/
50%
€1.27
Target price
28.08.24
€3.47
Performance (%)
-16.38%
Price
17.05.24
€1.06
Summary
This prediction is currently active. The price of Akebia Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.38%. This prediction currently runs until 28.08.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | -5.094% | -5.094% |
iShares Core DAX® | -0.383% | 5.021% |
iShares Nasdaq 100 | 1.248% | 4.007% |
iShares Nikkei 225® | 0.525% | -0.109% |
iShares S&P 500 | 0.640% | 3.649% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $3.75 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-41.78%
17.05.24
17.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
14.50%
17.05.24
17.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
-4.50%
17.05.24
17.05.24